From the Symposium Co-Chairs  
  Exhibitor Tutorials  
  Exhibitor Table Numbers  
  Program & Schedule  
  Wednesday  
  Thursday  
  Exhibitors  
  Event Sponsors  
  Media Partners  
  Program Committee  
  Home  
  < Upcoming SBS Events  
< SBS Home Page

 



Program & Schedule - Wednesday, Nov. 7, 2007

This meeting will provide an overview of the use of both primary cells and stem cells in high-throughput screening and the drug-discovery process.  Presentation topics will include: primary cells in drug discovery; primary cells as a tool for ADMET; stem cells & target validation; and emerging applications of stem cells.

Wednesday, November 7, 2007 Thursday, November 8 >
7:30am – 5:30pm Registration
7:30am – 8:45am Continental Breakfast, Visit Exhibits, Poster Viewing in Exhibit Hall
8:45am – 9:00am Welcome Remarks
Robert Ames, GlaxoSmithKline, USA
9:00am – 9:45am Plenary
Influence of Cell Phenotype on Pharmacology
Download Presentation
Robert Pacifici, CHDI, USA
Session 1: Primary Cells in Drug Discovery
Session Chair: Terry Riss, Promega Corporation, USA
Sponsored by PerkingElmer
9:45am – 10:30am Using Primary Cells for HTS Follow-up in a Physiologically Relevant System Download Presentation
Eric Johnson, Merck, USA
10:30am – 11:00am Networking Refreshment Break, Visit Exhibit, Poster Viewing in Exhibit Hall
11:00am – 11:45am Heterotrimeric G proteins: How Your Cell Type Can Make Difference in GPCR Signaling Download Presentation
Annette Gilchrist, Caden Bioscience, USA
11:45am – 12:30pm Drug Discovery Targeting Chemokine Receptors: Applications for AIDS, Cancer and Stem Cell Therapies detail^
Ziwei Huang, The Burnham Institute, USA
   
12:30pm – 2:00pm Lunch Break, Visit Exhibits, Poster Viewing in Exhibit Hall
Session 2:  Primary Cells as a Tool for ADMET
Session Chair: Ellen Berg, BioSeek, Inc., USA
2:00pm – 2:45pm Human Primary Cell-Based in vitro Experimental Systems for the Evaluation of Human Drug Safety detail^
Albert Li, The ADMET Group LLC, USA
2:45pm – 3:30pm Nuclear Receptor Activation: Comparison Between Primary Hepatocytes & Engineered Cell Lines detail^
Judy Raucy, Puracyp, Inc., USA
3:30pm - 4:15pm 3-D Co-culturing of Multiple Primary Cells for Drug Discovery, Diagnostics & Devices detail^
Dawn Applegate, RegeneMed. Inc., USA
4:15pm – 4:45pm Question & Answer Session
Session Chair: Ellen Berg
4:45pm – 5:30pm Vendor Tutorial Program I
5:30pm – 6:30pm Networking Welcome Reception
 

 

 

 

 


© 2007 - The Society for Biomolecular Sciences All rights reserved